Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fausto Bogazzi

Showing results (11-20 of 85) with videos related to

Pageof 9
Sort By:
Giornale Italiano Di Cardiologia (2006)|April 12, 2017
[Amiodarone-induced thyrotoxicosis]Fausto Bogazzi, Luca Tomisti, Vitantonio Di Bello, et al.
The Journal of Clinical Endocrinology and Metabolism|December 31, 2022
Real-life Data on the Effect of Medical Therapy for Amiodarone-induced Thyrotoxicosis on CV Events and HospitalizationsDaniele Cappellani, Giulia Marconcini, Luca Manetti, et al.
European Journal of Endocrinology|June 18, 2014
The onset time of amiodarone-induced thyrotoxicosis (AIT) depends on AIT typeLuca Tomisti, Giuseppe Rossi, Luigi Bartalena, et al.
The Journal of Clinical Endocrinology and Metabolism|August 26, 2011
Continuation of amiodarone delays restoration of euthyroidism in patients with type 2 amiodarone-induced thyrotoxicosis treated with prednisone: a pilot studyFausto Bogazzi, Luigi Bartalena, Luca Tomisti, et al.
Expert Opinion on Pharmacotherapy|June 15, 2005
An update on the pharmacological management of hyperthyroidism due to Graves' diseaseLuigi Bartalena, Maria Laura Tanda, Fausto Bogazzi, et al.
Langenbeck'S Archives of Surgery|November 15, 2006
Combination of minimally invasive thyroid surgery and local anesthesia associated to iopanoic acid for patients with amiodarone-induced thyrotoxicosis and severe cardiac disorders: a pilot studyPiero Berti, Gabriele Materazzi, Fausto Bogazzi, et al.
The Journal of Clinical Endocrinology and Metabolism|July 23, 2009
Glucocorticoids are preferable to thionamides as first-line treatment for amiodarone-induced thyrotoxicosis due to destructive thyroiditis: a matched retrospective cohort studyFausto Bogazzi, Luca Tomisti, Giuseppe Rossi, et al.
European Thyroid Journal|March 30, 2018
2018 European Thyroid Association (ETA) Guidelines for the Management of Amiodarone-Associated Thyroid DysfunctionLuigi Bartalena, Fausto Bogazzi, Luca Chiovato, et al.
Endocrinology|July 12, 2008
Transgenic mice overexpressing growth hormone (GH) have reduced or increased cardiac apoptosis through activation of multiple GH-dependent or -independent cell death pathwaysFausto Bogazzi, Dania Russo, Francesco Raggi, et al.
Clinical Endocrinology|October 11, 2008
Changes in the expression of suppressor of cytokine signalling (SOCS) 2 in the colonic mucosa of acromegalic patients are associated with hyperplastic polypsFausto Bogazzi, Federica Ultimieri, Francesco Raggi, et al.
Pageof 9

Showing results (11-20 of 85) with videos related to

Sort By:
Pageof 9
Giornale Italiano Di Cardiologia (2006)|April 12, 2017
[Amiodarone-induced thyrotoxicosis]Fausto Bogazzi, Luca Tomisti, Vitantonio Di Bello, et al.
The Journal of Clinical Endocrinology and Metabolism|December 31, 2022
Real-life Data on the Effect of Medical Therapy for Amiodarone-induced Thyrotoxicosis on CV Events and HospitalizationsDaniele Cappellani, Giulia Marconcini, Luca Manetti, et al.
European Journal of Endocrinology|June 18, 2014
The onset time of amiodarone-induced thyrotoxicosis (AIT) depends on AIT typeLuca Tomisti, Giuseppe Rossi, Luigi Bartalena, et al.
The Journal of Clinical Endocrinology and Metabolism|August 26, 2011
Continuation of amiodarone delays restoration of euthyroidism in patients with type 2 amiodarone-induced thyrotoxicosis treated with prednisone: a pilot studyFausto Bogazzi, Luigi Bartalena, Luca Tomisti, et al.
Expert Opinion on Pharmacotherapy|June 15, 2005
An update on the pharmacological management of hyperthyroidism due to Graves' diseaseLuigi Bartalena, Maria Laura Tanda, Fausto Bogazzi, et al.
Langenbeck'S Archives of Surgery|November 15, 2006
Combination of minimally invasive thyroid surgery and local anesthesia associated to iopanoic acid for patients with amiodarone-induced thyrotoxicosis and severe cardiac disorders: a pilot studyPiero Berti, Gabriele Materazzi, Fausto Bogazzi, et al.
The Journal of Clinical Endocrinology and Metabolism|July 23, 2009
Glucocorticoids are preferable to thionamides as first-line treatment for amiodarone-induced thyrotoxicosis due to destructive thyroiditis: a matched retrospective cohort studyFausto Bogazzi, Luca Tomisti, Giuseppe Rossi, et al.
European Thyroid Journal|March 30, 2018
2018 European Thyroid Association (ETA) Guidelines for the Management of Amiodarone-Associated Thyroid DysfunctionLuigi Bartalena, Fausto Bogazzi, Luca Chiovato, et al.
Endocrinology|July 12, 2008
Transgenic mice overexpressing growth hormone (GH) have reduced or increased cardiac apoptosis through activation of multiple GH-dependent or -independent cell death pathwaysFausto Bogazzi, Dania Russo, Francesco Raggi, et al.
Clinical Endocrinology|October 11, 2008
Changes in the expression of suppressor of cytokine signalling (SOCS) 2 in the colonic mucosa of acromegalic patients are associated with hyperplastic polypsFausto Bogazzi, Federica Ultimieri, Francesco Raggi, et al.
Pageof 9